Four posters presented at the American Pharmacists Association Annual Meeting and Exposition explored how individuals and health care providers have been handling the COVID-19 pandemic.
There has been much research released over the past few years on the COVID-19 pandemic and investigators have assessed the public health crisis’ impact on the population in several different areas of health care.
In 4 posters presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers examined fraudulent FDA-issued warning letters for COVID-19, vaccine hesitancy in college-aged adults, patient-health care provider communication regarding COVID-19, and comparisons of COVID-19 with peak influenza seasons.
Read more of our coverage from the 2024 APhA Annual Meeting & Exposition here.
Q&A: Factors Showing Tirzepatide is More Beneficial Than Semaglutide | ASHP Midyear
Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed the benefits of tirzepatide compared with semaglutide.